BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37097545)

  • 1. Hairy Cell Leukemia: Where Are We in 2023?
    Mendez-Hernandez A; Moturi K; Hanson V; Andritsos LA
    Curr Oncol Rep; 2023 Aug; 25(8):833-840. PubMed ID: 37097545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
    Paillassa J; Maitre E; Troussard X
    Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
    Kreitman RJ; Arons E
    Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials.
    Robak T; Robak P
    Expert Opin Investig Drugs; 2023 Apr; 32(4):311-324. PubMed ID: 36931901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant.
    King AC; Kabel CC; Pappacena JJ; Stump SE; Daley RJ
    Ann Pharmacother; 2019 Sep; 53(9):922-932. PubMed ID: 30841702
    [No Abstract]   [Full Text] [Related]  

  • 6. How I manage patients with hairy cell leukaemia.
    Thompson PA; Ravandi F
    Br J Haematol; 2017 May; 177(4):543-556. PubMed ID: 28146266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hairy cell leukemia.
    Chihara D; Kreitman RJ
    Expert Rev Hematol; 2020 Oct; 13(10):1107-1117. PubMed ID: 32893700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic options for relapsed hairy cell leukemia.
    Jain P; Polliack A; Ravandi F
    Leuk Lymphoma; 2015; 56(8):2264-72. PubMed ID: 25563425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; MaƮtre E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological management of hairy cell leukemia.
    Ramos Perez J; Ravandi-Kashani F
    Expert Opin Pharmacother; 2020 Aug; 21(11):1337-1344. PubMed ID: 32378970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
    Paillassa J; Safa F; Troussard X
    Ther Adv Hematol; 2022; 13():20406207221090886. PubMed ID: 35450208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia: present and future directions.
    Kreitman RJ
    Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Treatment of Hairy Cell Leukemia Variant.
    Tran J; Gaulin C; Tallman MS
    Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxetumomab pasudotox for the treatment of hairy cell leukemia.
    Janus A; Robak T
    Expert Opin Biol Ther; 2019 Jun; 19(6):501-508. PubMed ID: 31045462
    [No Abstract]   [Full Text] [Related]  

  • 15. Hairy Cell Leukaemia.
    Cross M; Dearden C
    Curr Oncol Rep; 2020 Apr; 22(5):42. PubMed ID: 32297104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?].
    Troussard X; Maitre E; Paillassa J
    Bull Cancer; 2021; 108(7-8):771-778. PubMed ID: 34023063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors.
    Falini B; De Carolis L; Tiacci E
    Blood; 2022 Apr; 139(15):2294-2305. PubMed ID: 35143639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutics in hairy cell leukemia.
    Sarvaria A; Saven A
    Expert Rev Hematol; 2019 Nov; 12(11):983-987. PubMed ID: 31380711
    [No Abstract]   [Full Text] [Related]  

  • 19. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoimmunotherapy for hairy cell leukemia.
    Ravandi F
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.